Pediatric hemostasis and use of plasma components

Best Practice and Research: Clinical Haematology

Volumn 19, Issue 1, 2006, Pages 143-155

  Goldenberg, Neil A ^a,b,c   Manco Johnson, Marilyn J ^a,b,c  

^a UNIVERSITY OF COLORADO   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c Mountain States Regional Hemophilia and Thrombosis Center   (United States)

Author keywords

Newborn infant and children; Plasma component therapies

Indexed keywords

ACTIVATED PROTEIN C; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTITHROMBIN; APROTININ; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 13 CONCENTRATE; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 CRYOPRECIPITATE; BLOOD DERIVATIVE; DESMOPRESSIN; DROTRECOGIN; FIBRINOGEN; FRESH FROZEN PLASMA; HEPARIN; MEMBRANE COFACTOR PROTEIN; OXYGEN; PARACETAMOL; PLACEBO; PLASMINOGEN; PROCOAGULANT; PROTEIN C; PROTEIN S; PROTHROMBIN COMPLEX; UNINDEXED DRUG; VITAMIN K GROUP; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

BLEEDING DISORDER; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; CARDIOPULMONARY BYPASS; CHILD; CHILD HEALTH CARE; CLINICAL TRIAL; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG APPROVAL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG FATALITY; DRUG HALF LIFE; DRUG METABOLISM; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; EXTRACORPOREAL OXYGENATION; GRAM NEGATIVE SEPSIS; HEART INFARCTION; HEMOLYTIC UREMIC SYNDROME; HEMOPHILIA A; HEMOSTASIS; HUMAN; HYPERVISCOSITY SYNDROME; INFANT; LIVER BIOPSY; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; META ANALYSIS; NEWBORN; POLYCYTHEMIA; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; REVIEW; SYSTEMATIC REVIEW; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION; UNITED STATES; VASOSPASM;

BLOOD COMPONENT TRANSFUSION; CHILD; CHILD, PRESCHOOL; DISSEMINATED INTRAVASCULAR COAGULATION; HEMORRHAGE; HEMOSTASIS; HUMANS; INFANT; INFANT, NEWBORN; LIVER DISEASES; PLASMA; SEPSIS;

EID: 31044433068     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2005.03.006     Document Type: Review

References (58)

1. M. Andrew P. Vegh M. Johnston et al. Maturation of the hemostatic system during childhood Blood 80 1992 1998-2005
2. M.M. Flanders R.A. Crist W.M. Roberts & G.M. Rodgers Pediatric reference intervals for ten coagulation assays Blood 104 2004 A2988 [Abstract]
3. D.F. O'Shaughnessy C. Atterbury P.B. Maggs et al. (For the British Committee for Standards in Haematology Blood Transfusion Task Force.) Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant Br J Haematol 126 2004 11-28
4. J.H. McAfee E.B. Keeffe R.G. Lee & J. Rosch Transjugular liver biopsy Hepatology 15 1992 726-732
5. U. Denzer I. Helmreich-Becker P.R. Galle & A.W. Lohse Liver assessment and biopsy in patients with marked coagulopathy: Value of mini-laparoscopy and control of bleeding Am J Gastroenterol 98 2003 893-900
6. A. Chuansumrit S. Treepongkaruna &. P. Phuapradit Combined fresh frozen plasma with recombinant factor VIIa in restoring hemostasis for invasive procedures in children with liver diseases Thromb Haemost 85 2001 748-749
7. J.B. Brown K.M. Emerick D.L. Brown et al. Recombinant factor VIIa improved coagulopathy caused by liver failure J Pediatr Gastroenterol Nutr 37 2003 268-272
8. V.M. Shami S.H. Caldwell E.E. Hespenheide et al. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy Liver Transpl 9 2003 138-143
9. D.M. DiMichele & W.E. Hathaway Use of DDAVP in inherited and acquired platelet dysfunction Am J Hematol 33 1990 39-45
10. G.R. Bernard J.L. Vincent P.F. Laterre et al. Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 2001 699-709
11. M. Levi & H. ten Cate Disseminated intravascular coagulation N Engl J Med 341 1999 586-592
12. K.B. Churchwell M.L. McManus P. Kent et al. Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia J Clin Apheresis 10 1995 171-174
13. M. Hellgren L. Javelin K. Hägnevik & M. Blombäck Antithrombin III concentrate as adjuvant in DIC treatment: A pilot study in 9 severely ill patients Thromb Res 35 1984 459-466
14. R. von Kries H. Stannigel & U. Göbel Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation Eur J Pediatr 144 1985 191-194
15. T. Hanada T. Abe & H. Takita Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children Am J Pediatr Hematol Oncol 7 1985 3-8
16. B. Blauhut H. Kramar H. Vinazzer & H. Bergmann Substitution of antithrombin III in shock and DIC: A randomized study Thromb Res 39 1985 81-89
17. S. Fuse H. Tomita M. Yoshida et al. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children Am J Hematol 53 1996 18-21
18. B. Eisele M. Lamy H.O. Keinecke et al. Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled double-blind trials with antithrombin III in severe sepsis Intensive Care Med 24 1998 663-672
19. W.D. Kreuz W. Schneider & U. Nowak-Göttl Treatment of consumption cogulopathy with antithrombin concentrate in children with acquired antithrombin deficiency-a feasibility pilot study Eur J Pediatr 158 supplement 3 1999 S187-S191
20. M. Dreyfus J.F. Magny F. Briney et al. Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate N Engl J Med 325 1991 1565-1568
21. W.T. Gerson J.D. Dickermann E.G. Bovill & E. Golden Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: Treatment with protein C concentate Pediatrics 91 1993 418-422
22. G.E. Rivard M. David C. Farrell & H.P. Schwarz Treatment of purpura fulminans in meningococcemia with protein C concentrate J Pediatr 126 1995 646-652
23. C.E. Ettingshausen A. Veldmann T. Beeg et al. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans Semin Thromb Hemost 25 1999 537-541
24. I. Sajan S.S. Da-Silva & R.P. Dellinger Drotrecogin alpha (activated) in an infant with Gram-negative septic shock J Intensive Care Med 19 2004 51-55
25. G.A. Rock K.H. Shumark N.A. Buskard et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura N Engl J Med 325 1991 393-397
26. G. Rock K.H. Shumark D.M.C. Sutton et al. Cryosupernatant as replacement fluid for plasma exchange in the thrombotic thrombocytopenic purpura Br J Haematol 39 1996 1227-1234
27. Z.R. Zeigler R.K. Shadduck J.F. Gryn et al. Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura J Clin Apheresis 16 2001 19-22
28. T.M. Horton J.D. Stone D. Yee et al. Case series of thrombotic thrombocytopenic purpura in children and adolescents J Pediatr Hematol Oncol 25 2003 336-339
29. J.N. George How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Blood 96 2000 1223-1229
30. G. Rizzoni A. Claris-Appiani A. Edefonti et al. Plasma infusion for hemolytic-uremic syndrome in children: Results of a multicenter controlled trial J Pediatr 112 1988 284-290
31. C. Loirat E. Sonsino N. Hinglais et al. Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicenter randomized controlled trial Pediatr Nephrol 2 1988 279-285
32. A. Gianviti A. Perna A. Caringella et al. Plasma exchange in children with hemolytic-uremic syndrome at risk of poor outcome Am J Kidney Dis 22 1993 264-266
33. A. Richards E.J. Kemp M.K. Liszewski et al. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome PNAS 100 2003 12966-12971
34. H. Yagi M. Konno S. Kinoshita et al. Plasma of patients with Upshaw-Schulman syndrome, a congenital deficiency of von Willebrand factor-cleaving protease activity, enhances the aggregation of normal platelets under high shear stress Br J Haematol 115 2001 991-997
35. M.M. McDonald B.L. Koops M.L. Johnson et al. Timing and antecedents of intracranial hemorrhage in the newborn Pediatrics 74 1984 32-36
36. D.W. Beverley T.J. Pitts-Tucker P.J. Congdon et al. Prevention of intraventricular haemorrhage by fresh frozen plasma Arch Dis Child 60 1985 710-713
37. Northern Neonatal Nursing Initiative Trial Group Randomised trial of prophylactic early fresh-frozen plasma or gelatin or glucose in preterm babies: Outcome at 2 years Lancet 348 1996 229-232
38. D.A. Osborn & N. Evans Early volume expansion for prevention of morbidity and mortality in very preterm infants Cochrane Database Syst Rev 2 2004 CD002055
39. S.S. Mou B.P. Giroir E.A. Molitor-Kirsch et al. Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants N Engl J Med 351 2004 1635-1644
40. J. Petaja U. Lundstrom M. Leijala et al. Bleeding and use of blood products after heart operations in infants J Thorac Cardiovasc Surg 109 1995 524-529
41. F. Nicolas J.P. Daniel J. Bruniaux et al. Conventional cardiopulmonary bypass in neonates. A physiological approach - 10 years of experience at Marie-Lannelongue Hospital Perfusion 9 1994 41-48
42. L.A. Chambers D.M. Cohen & J.T. Davis Transfusion patterns in pediatric open heart surgery Transfusion 36 1996 150-154
43. M. Pychynska-Pokorska J.J. Moll W. Krajewski & P. Jarosik The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass Pediatr Crit Care Med 5 2004 246-250
44. J.D. Tobias J.M. Simsic S. Weinstein et al. Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients J Intensive Care Med 19 2004 270-273
45. J.M. Costello C.L. Backer A. de Hoyos et al. Aprotinin reduces operative closure time and blood product use after pediatric bypass Ann Thorac Surg 75 2003 1261-1266
46. L.M. Reynolds S.C. Nicholson D.R. Jobes et al. Desmopressin does not decrease bleeding after cardiac operation in your children J Thorac Cardiovasc Surg 106 1993 954-958
47. M.D. Seear L.D. Wadsworth P.C. Rogers et al. The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children J Thorac Cardiovasc Surg 98 1989 217-219
48. E.M. Rosenberg L.A. Chambers J.M. & Gunter J.A. Good A program to limit donor exposures to neonates undergoing extracorporeal membrane oxygenation Pediatrics 94 1994 341-346
49. D. McCoy-Pardington W.J. Judd P. Knafl et al. Blood use during extracorporeal membrane oxygenation Transfusion 30 1990 307-309
50. S. Supapannachart P. Siripoonya W. Boonwattanasoontorn & A. Kanjanavanit Neonatal polycythemia: Effects of partial exchange transfusion using fresh frozen plasma, haemaccel and normal saline J Med Assoc Thai 82 supplment 1 1999 S82-S86
51. A.K. Deorari V.K. Paul L. Shreshta & M. Singh Symptomatic neonatal polycythemia: Comparison of partial exchange transfusion with saline versus plasma Indian Pediatr 32 1995 1167-1171
52. A. Roithmaier R. Arlettaz K. Bauer et al. Randomized controlled trial of Ringer solution versus serum for partial exchange transfusion in neonatal polycythaemia Eur J Pediatr 154 1995 53-56
53. T. Tothenberg Partial plasma exchange transfusion in polycythemic neonates Arch Dis Child 86 2002 60-62
54. T.S. Rosenkrantz Polycythemia and hyperviscosity in the newborn Semin Thromb Hemost 29 2003 515-527
55. B.C. McLeod R.J. Sassetti E.R. Cole & J.P. Scott Long-term frequent plasma exchange donation of cryoprecipitate Transfusion 28 1988 307-310
56. B.C. McLeod & J.P. Scott Plasma exchange donation of cryoprecipitate after DDAVP stimulation: An alternative source of factor VIII Prog Clin Biol Res 324 1990 189-198
57. W.P. Fay A.C. Parker L.R. Condrey & A.D. Shapiro Human plasminogen activator inhibitor-1 (PAI-1) deficiency: Characterization of a large kindred with a null mutation in the PAI-1 gene Blood 90 1997 204-208
58. K. Brummel Ziedins G.E. Rivard R.L. Pouliot et al. Factor VIIa replacement therapy in factor VII deficiency J Thromb Haemost 2 2004 1735-1744